

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 4.95327091 |
| 2 | alpha-linolenic acid metabolic process (GO:0036109) | 4.88595574 |
| 3 | complement activation, alternative pathway (GO:0006957) | 4.87551450 |
| 4 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 4.51855856 |
| 5 | L-phenylalanine catabolic process (GO:0006559) | 4.51855856 |
| 6 | regulation of protein activation cascade (GO:2000257) | 4.48516587 |
| 7 | regulation of complement activation (GO:0030449) | 4.32213321 |
| 8 | plasma lipoprotein particle clearance (GO:0034381) | 4.30860207 |
| 9 | positive regulation of heterotypic cell-cell adhesion (GO:0034116) | 4.26511428 |
| 10 | low-density lipoprotein particle clearance (GO:0034383) | 4.25695666 |
| 11 | protein carboxylation (GO:0018214) | 4.21920220 |
| 12 | peptidyl-glutamic acid carboxylation (GO:0017187) | 4.21920220 |
| 13 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 4.18110766 |
| 14 | L-phenylalanine metabolic process (GO:0006558) | 4.18110766 |
| 15 | urea metabolic process (GO:0019627) | 4.08347488 |
| 16 | urea cycle (GO:0000050) | 4.08347488 |
| 17 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 4.01892194 |
| 18 | aromatic amino acid family catabolic process (GO:0009074) | 3.96736209 |
| 19 | detection of molecule of bacterial origin (GO:0032490) | 3.92057859 |
| 20 | high-density lipoprotein particle remodeling (GO:0034375) | 3.87957494 |
| 21 | glucocorticoid biosynthetic process (GO:0006704) | 3.84802486 |
| 22 | positive regulation of fatty acid beta-oxidation (GO:0032000) | 3.84615734 |
| 23 | bile acid biosynthetic process (GO:0006699) | 3.81281051 |
| 24 | negative regulation of fibrinolysis (GO:0051918) | 3.80927089 |
| 25 | regulation of triglyceride catabolic process (GO:0010896) | 3.79309360 |
| 26 | sulfur amino acid catabolic process (GO:0000098) | 3.75231472 |
| 27 | * reverse cholesterol transport (GO:0043691) | 3.68156099 |
| 28 | nitrogen cycle metabolic process (GO:0071941) | 3.67291602 |
| 29 | plasma lipoprotein particle remodeling (GO:0034369) | 3.65687539 |
| 30 | protein-lipid complex remodeling (GO:0034368) | 3.65687539 |
| 31 | macromolecular complex remodeling (GO:0034367) | 3.65687539 |
| 32 | regulation of fibrinolysis (GO:0051917) | 3.63705353 |
| 33 | regulation of cytokine secretion involved in immune response (GO:0002739) | 3.57291544 |
| 34 | positive regulation of lipid catabolic process (GO:0050996) | 3.51572798 |
| 35 | acylglycerol homeostasis (GO:0055090) | 3.49932799 |
| 36 | triglyceride homeostasis (GO:0070328) | 3.49932799 |
| 37 | regulation of cholesterol esterification (GO:0010872) | 3.49269391 |
| 38 | indole-containing compound catabolic process (GO:0042436) | 3.48399241 |
| 39 | indolalkylamine catabolic process (GO:0046218) | 3.48399241 |
| 40 | tryptophan catabolic process (GO:0006569) | 3.48399241 |
| 41 | tryptophan metabolic process (GO:0006568) | 3.48072342 |
| 42 | oligosaccharide catabolic process (GO:0009313) | 3.47246909 |
| 43 | kynurenine metabolic process (GO:0070189) | 3.41435705 |
| 44 | retina vasculature morphogenesis in camera-type eye (GO:0061299) | 3.39903912 |
| 45 | bile acid metabolic process (GO:0008206) | 3.39826518 |
| 46 | glyoxylate metabolic process (GO:0046487) | 3.38422789 |
| 47 | low-density lipoprotein particle remodeling (GO:0034374) | 3.37939555 |
| 48 | cysteine metabolic process (GO:0006534) | 3.35983783 |
| 49 | cellular response to follicle-stimulating hormone stimulus (GO:0071372) | 3.35821074 |
| 50 | * phospholipid homeostasis (GO:0055091) | 3.32741900 |
| 51 | complement activation (GO:0006956) | 3.32023486 |
| 52 | * phospholipid efflux (GO:0033700) | 3.28015458 |
| 53 | homocysteine metabolic process (GO:0050667) | 3.27829855 |
| 54 | * regulation of cholesterol storage (GO:0010885) | 3.24994453 |
| 55 | regulation of heterotypic cell-cell adhesion (GO:0034114) | 3.23081844 |
| 56 | complement activation, classical pathway (GO:0006958) | 3.20887521 |
| 57 | * cholesterol efflux (GO:0033344) | 3.20173981 |
| 58 | positive regulation of fatty acid oxidation (GO:0046321) | 3.20091278 |
| 59 | tyrosine metabolic process (GO:0006570) | 3.18825154 |
| 60 | regulation of mononuclear cell migration (GO:0071675) | 3.18559481 |
| 61 | positive regulation of membrane protein ectodomain proteolysis (GO:0051044) | 3.17609887 |
| 62 | amino-acid betaine metabolic process (GO:0006577) | 3.17560844 |
| 63 | regulation of fatty acid beta-oxidation (GO:0031998) | 3.13147100 |
| 64 | keratan sulfate catabolic process (GO:0042340) | 3.12480587 |
| 65 | regulation of membrane protein ectodomain proteolysis (GO:0051043) | 3.10787301 |
| 66 | fibrinolysis (GO:0042730) | 3.10186564 |
| 67 | protein activation cascade (GO:0072376) | 3.08532809 |
| 68 | * plasma lipoprotein particle assembly (GO:0034377) | 3.07094920 |
| 69 | regulation of sequestering of triglyceride (GO:0010889) | 3.07053600 |
| 70 | * lipoprotein metabolic process (GO:0042157) | 3.06423966 |
| 71 | negative regulation of protein activation cascade (GO:2000258) | 3.04367681 |
| 72 | apoptotic cell clearance (GO:0043277) | 2.99488657 |
| 73 | fatty acid transmembrane transport (GO:1902001) | 2.98217755 |
| 74 | regulation of macrophage chemotaxis (GO:0010758) | 2.97892793 |
| 75 | lysine metabolic process (GO:0006553) | 2.97340206 |
| 76 | lysine catabolic process (GO:0006554) | 2.97340206 |
| 77 | positive regulation of interleukin-8 biosynthetic process (GO:0045416) | 2.97226813 |
| 78 | dicarboxylic acid biosynthetic process (GO:0043650) | 2.96231382 |
| 79 | bile acid and bile salt transport (GO:0015721) | 2.95758962 |
| 80 | * plasma lipoprotein particle organization (GO:0071827) | 2.95489412 |
| 81 | cell adhesion mediated by integrin (GO:0033627) | 2.95320106 |
| 82 | regulation of fever generation (GO:0031620) | 2.94578327 |
| 83 | negative regulation of sterol transport (GO:0032372) | 2.94111225 |
| 84 | negative regulation of cholesterol transport (GO:0032375) | 2.94111225 |
| 85 | glucocorticoid metabolic process (GO:0008211) | 2.94044382 |
| 86 | regulation of cholesterol homeostasis (GO:2000188) | 2.93759158 |
| 87 | valine metabolic process (GO:0006573) | 2.90842074 |
| 88 | serine family amino acid catabolic process (GO:0009071) | 2.90364881 |
| 89 | positive regulation of cellular amide metabolic process (GO:0034250) | 2.89381546 |
| 90 | branching involved in labyrinthine layer morphogenesis (GO:0060670) | 2.89021130 |
| 91 | positive regulation vascular endothelial growth factor production (GO:0010575) | 2.88001141 |
| 92 | cellular modified amino acid catabolic process (GO:0042219) | 2.87178232 |
| 93 | * protein-lipid complex assembly (GO:0065005) | 2.87046703 |
| 94 | negative regulation of lipase activity (GO:0060192) | 2.85703469 |
| 95 | regulation of cholesterol biosynthetic process (GO:0045540) | 2.85187920 |
| 96 | * protein-lipid complex subunit organization (GO:0071825) | 2.84902456 |
| 97 | response to follicle-stimulating hormone (GO:0032354) | 2.84271531 |
| 98 | fatty acid beta-oxidation (GO:0006635) | 2.83666338 |
| 99 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 2.83393710 |
| 100 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 2.83393710 |
| 101 | modulation by symbiont of host immune response (GO:0052553) | 2.83393710 |
| 102 | positive regulation by symbiont of host defense response (GO:0052509) | 2.83393710 |
| 103 | modulation by symbiont of host defense response (GO:0052031) | 2.83393710 |
| 104 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 2.83393710 |
| 105 | cellular response to thyroid hormone stimulus (GO:0097067) | 2.83348953 |
| 106 | * negative regulation of macrophage derived foam cell differentiation (GO:0010745) | 2.83242218 |
| 107 | positive regulation of blood coagulation (GO:0030194) | 2.82451573 |
| 108 | positive regulation of hemostasis (GO:1900048) | 2.82451573 |
| 109 | regulation of vascular endothelial growth factor production (GO:0010574) | 2.82142760 |
| 110 | lipid oxidation (GO:0034440) | 2.80980623 |
| 111 | * positive regulation of cholesterol efflux (GO:0010875) | 2.80839513 |
| 112 | fatty acid oxidation (GO:0019395) | 2.80689792 |
| 113 | positive regulation of steroid metabolic process (GO:0045940) | 2.80011925 |
| 114 | alpha-amino acid catabolic process (GO:1901606) | 2.79096798 |
| 115 | * cholesterol homeostasis (GO:0042632) | 2.78186706 |
| 116 | cellular response to ethanol (GO:0071361) | 2.77386258 |
| 117 | * positive regulation of sterol transport (GO:0032373) | 2.76476617 |
| 118 | * positive regulation of cholesterol transport (GO:0032376) | 2.76476617 |
| 119 | regulation of apoptotic cell clearance (GO:2000425) | 2.76425016 |
| 120 | regulation of heat generation (GO:0031650) | 2.76174340 |
| 121 | * sterol homeostasis (GO:0055092) | 2.76134148 |
| 122 | very-low-density lipoprotein particle assembly (GO:0034379) | 2.75572246 |
| 123 | aromatic amino acid family metabolic process (GO:0009072) | 2.74930028 |
| 124 | regulation of lipid catabolic process (GO:0050994) | 2.74892403 |
| 125 | acute-phase response (GO:0006953) | 2.74545846 |
| 126 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 2.74259422 |
| 127 | fatty acid homeostasis (GO:0055089) | 2.74017280 |
| 128 | linoleic acid metabolic process (GO:0043651) | 2.73514958 |
| 129 | positive regulation of triglyceride metabolic process (GO:0090208) | 2.72984133 |
| 130 | negative regulation of complement activation (GO:0045916) | 2.61675281 |
| 131 | positive regulation of heat generation (GO:0031652) | 2.60635953 |
| 132 | regulation of chemokine-mediated signaling pathway (GO:0070099) | 2.57360891 |
| 133 | * sterol transport (GO:0015918) | 2.56092488 |
| 134 | * cholesterol transport (GO:0030301) | 2.56092488 |
| 135 | serine transport (GO:0032329) | 2.54260717 |
| 136 | C21-steroid hormone biosynthetic process (GO:0006700) | 2.53641768 |
| 137 | glycosphingolipid catabolic process (GO:0046479) | 2.53546507 |
| 138 | L-serine transport (GO:0015825) | 2.50107333 |
| 139 | amino sugar catabolic process (GO:0046348) | 2.40467506 |
| 140 | positive regulation of coagulation (GO:0050820) | 2.40351041 |
| 141 | interleukin-6-mediated signaling pathway (GO:0070102) | 2.38977953 |
| 142 | negative regulation of platelet activation (GO:0010544) | 2.37548311 |
| 143 | negative regulation of cytokine production involved in immune response (GO:0002719) | 2.32805375 |
| 144 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 2.32797691 |
| 145 | regulation of interleukin-8 biosynthetic process (GO:0045414) | 2.27174400 |
| 146 | response to methylmercury (GO:0051597) | 2.25041048 |
| 147 | progesterone metabolic process (GO:0042448) | 2.24617855 |
| 148 | negative regulation of hemostasis (GO:1900047) | 2.23735442 |
| 149 | negative regulation of blood coagulation (GO:0030195) | 2.23735442 |
| 150 | negative regulation of production of molecular mediator of immune response (GO:0002701) | 2.21750025 |
| 151 | negative regulation of coagulation (GO:0050819) | 2.21599110 |
| 152 | * response to lipoprotein particle (GO:0055094) | 2.21323954 |
| 153 | glycolipid catabolic process (GO:0019377) | 2.21298902 |
| 154 | C21-steroid hormone metabolic process (GO:0008207) | 2.19831883 |
| 155 | positive regulation of chemokine secretion (GO:0090197) | 2.19171946 |
| 156 | positive regulation of extracellular matrix organization (GO:1903055) | 2.17951723 |
| 157 | positive regulation of lipid storage (GO:0010884) | 2.16915599 |
| 158 | transcytosis (GO:0045056) | 2.16903363 |
| 159 | * negative regulation of lipid storage (GO:0010888) | 2.15093294 |
| 160 | ovulation from ovarian follicle (GO:0001542) | 2.14740572 |
| 161 | ceramide catabolic process (GO:0046514) | 2.13028440 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 6.89227517 |
| 2 | * RXR_22158963_ChIP-Seq_LIVER_Mouse | 5.09435123 |
| 3 | * LXR_22158963_ChIP-Seq_LIVER_Mouse | 4.49757064 |
| 4 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 4.31820627 |
| 5 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 4.25387908 |
| 6 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 3.62106829 |
| 7 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 3.46629135 |
| 8 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 2.99324718 |
| 9 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 2.44985511 |
| 10 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 2.28309177 |
| 11 | * CLOCK_20551151_ChIP-Seq_293T_Human | 2.25608173 |
| 12 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 2.20922613 |
| 13 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 2.20184826 |
| 14 | GBX2_23144817_ChIP-Seq_PC3_Human | 2.16963808 |
| 15 | GATA1_22025678_ChIP-Seq_K562_Human | 2.10384847 |
| 16 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.96068716 |
| 17 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.94364193 |
| 18 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.83248353 |
| 19 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.77877842 |
| 20 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.77504359 |
| 21 | * IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.70829714 |
| 22 | * SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.70207246 |
| 23 | WT1_19549856_ChIP-ChIP_CCG9911_Human | 1.68903280 |
| 24 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.62188313 |
| 25 | * FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.61699345 |
| 26 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 1.59900565 |
| 27 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.59034025 |
| 28 | * P300_19829295_ChIP-Seq_ESCs_Human | 1.56630942 |
| 29 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 1.55623839 |
| 30 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 1.53717954 |
| 31 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 1.51010878 |
| 32 | * BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.50669171 |
| 33 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.48191639 |
| 34 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.47664684 |
| 35 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 1.45900183 |
| 36 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 1.45805650 |
| 37 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.45665809 |
| 38 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.44208228 |
| 39 | SMAD3_21741376_ChIP-Seq_HESCs_Human | 1.43915258 |
| 40 | * SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.43186120 |
| 41 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.40420991 |
| 42 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.39261153 |
| 43 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 1.38383468 |
| 44 | * SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.36370853 |
| 45 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.35282666 |
| 46 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.34974925 |
| 47 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.34867867 |
| 48 | CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 1.33316078 |
| 49 | * RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.32956109 |
| 50 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 1.32469535 |
| 51 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.31290538 |
| 52 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 1.31205214 |
| 53 | TP53_18474530_ChIP-ChIP_U2OS_Human | 1.30387897 |
| 54 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.29717528 |
| 55 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 1.29466508 |
| 56 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.29385554 |
| 57 | EBF1_22473956_ChIP-Seq_BONE_MARROW_Mouse | 1.28069133 |
| 58 | NANOG_18555785_Chip-Seq_ESCs_Mouse | 1.27950130 |
| 59 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 1.26543445 |
| 60 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 1.26543445 |
| 61 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.25594520 |
| 62 | * ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.24355319 |
| 63 | * NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.24040682 |
| 64 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 1.23814789 |
| 65 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.23465747 |
| 66 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.22063593 |
| 67 | * BRD4_25478319_ChIP-Seq_HGPS_Human | 1.21978765 |
| 68 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 1.20877417 |
| 69 | * ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.19963560 |
| 70 | * PPAR_26484153_Chip-Seq_NCI-H1993_Human | 1.19847564 |
| 71 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.19198729 |
| 72 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 1.18285508 |
| 73 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 1.17898262 |
| 74 | SMAD4_21741376_ChIP-Seq_HESCs_Human | 1.14745648 |
| 75 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 1.14451403 |
| 76 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.14190427 |
| 77 | CRX_20693478_ChIP-Seq_RETINA_Mouse | 1.13794605 |
| 78 | CDX2_22108803_ChIP-Seq_LS180_Human | 1.13598263 |
| 79 | AR_25329375_ChIP-Seq_VCAP_Human | 1.11668662 |
| 80 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.11359755 |
| 81 | TAF15_26573619_Chip-Seq_HEK293_Human | 1.10417429 |
| 82 | E2F1_18555785_Chip-Seq_ESCs_Mouse | 1.10168014 |
| 83 | NANOG_18700969_ChIP-ChIP_MESCs_Mouse | 1.08505228 |
| 84 | * VDR_24787735_ChIP-Seq_THP-1_Human | 1.07961904 |
| 85 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 1.07391704 |
| 86 | SUZ12_18555785_Chip-Seq_ESCs_Mouse | 1.06614689 |
| 87 | OCT4_21477851_ChIP-Seq_ESCs_Mouse | 1.06289005 |
| 88 | CMYC_18555785_Chip-Seq_ESCs_Mouse | 1.06253462 |
| 89 | CJUN_26792858_Chip-Seq_BT549_Human | 1.05727188 |
| 90 | GATA1_19941826_ChIP-Seq_K562_Human | 1.04682862 |
| 91 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.04284627 |
| 92 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 1.03723701 |
| 93 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.03715220 |
| 94 | P53_22387025_ChIP-Seq_ESCs_Mouse | 1.03272666 |
| 95 | * STAT3_23295773_ChIP-Seq_U87_Human | 1.01253071 |
| 96 | MEIS1_26923725_Chip-Seq_HEMOGENIC-ENDOTHELIUM_Mouse | 0.99857588 |
| 97 | TCF4_18268006_ChIP-ChIP_LS174T_Human | 0.99493460 |
| 98 | * PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.99233994 |
| 99 | * CEBPD_21427703_ChIP-Seq_3T3-L1_Mouse | 0.98966397 |
| 100 | * HNF4A_19822575_ChIP-Seq_HepG2_Human | 0.97859179 |
| 101 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.97753157 |
| 102 | * TAL1_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.97413662 |
| 103 | * P300_18555785_Chip-Seq_ESCs_Mouse | 0.97211100 |
| 104 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 0.96755169 |
| 105 | * SMAD4_21741376_ChIP-Seq_EPCs_Human | 0.95187390 |
| 106 | * FOXM1_26456572_ChIP-Seq_MCF-7_Human | 0.95174020 |
| 107 | RUNX_20019798_ChIP-Seq_JUKART_Human | 0.93204357 |
| 108 | BCAT_22108803_ChIP-Seq_LS180_Human | 0.93158827 |
| 109 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 0.92483995 |
| 110 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 0.91563432 |
| 111 | * SOX9_24532713_ChIP-Seq_HFSC_Mouse | 0.91287838 |
| 112 | GATA2_19941826_ChIP-Seq_K562_Human | 0.90533485 |
| 113 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 0.90527197 |
| 114 | * AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.89985463 |
| 115 | * PPARG_20176806_ChIP-Seq_3T3-L1_Mouse | 0.89009099 |
| 116 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 0.88048318 |
| 117 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.87794565 |
| 118 | NFIB_24661679_ChIP-Seq_LUNG_Mouse | 0.86410153 |
| 119 | * AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 0.85529335 |
| 120 | SOX2_20726797_ChIP-Seq_SW620_Human | 0.84288200 |
| 121 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 0.84211131 |
| 122 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 0.84182738 |
| 123 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.84080554 |
| 124 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 0.83480786 |
| 125 | AHR_22903824_ChIP-Seq_MCF-7_Human | 0.81975234 |
| 126 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 0.81255550 |
| 127 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 0.81205012 |
| 128 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 0.80966671 |
| 129 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 0.80966671 |
| 130 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 0.80314098 |
| 131 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 0.79919043 |
| 132 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 0.78511712 |
| 133 | RXR_22108803_ChIP-Seq_LS180_Human | 0.77595947 |
| 134 | TP63_23658742_ChIP-Seq_EP156T_Human | 0.75738638 |
| 135 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 0.75642646 |
| 136 | TP53_16413492_ChIP-PET_HCT116_Human | 0.74613305 |
| 137 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.74467600 |
| 138 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 0.73073932 |
| 139 | PPARG_20887899_ChIP-Seq_3T3-L1_Mouse | 0.72892679 |
| 140 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 0.71906185 |
| 141 | GATA4_25053715_ChIP-Seq_YYC3_Human | 0.70720083 |
| 142 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 0.70437767 |
| 143 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 0.70033518 |
| 144 | FOXA1_25552417_ChIP-Seq_VCAP_Human | 0.69955003 |
| 145 | SCL_19346495_ChIP-Seq_HPC-7_Human | 0.69084540 |
| 146 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 0.67312665 |
| 147 | WT1_25993318_ChIP-Seq_PODOCYTE_Human | 0.62903515 |
| 148 | SPI1_23127762_ChIP-Seq_K562_Human | 0.62295774 |
| 149 | FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.61587313 |
| 150 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.60910638 |
| 151 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 0.59823341 |
| 152 | PU_27001747_Chip-Seq_BMDM_Mouse | 0.59754400 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0006054_spinal_hemorrhage | 5.44391476 |
| 2 | MP0002139_abnormal_hepatobiliary_system | 5.36909498 |
| 3 | MP0005360_urolithiasis | 5.02510642 |
| 4 | MP0005365_abnormal_bile_salt | 4.49012501 |
| 5 | MP0005085_abnormal_gallbladder_physiolo | 4.07108302 |
| 6 | MP0003252_abnormal_bile_duct | 3.36564808 |
| 7 | MP0008004_abnormal_stomach_pH | 3.29849675 |
| 8 | * MP0010329_abnormal_lipoprotein_level | 3.18397636 |
| 9 | MP0009840_abnormal_foam_cell | 3.13565329 |
| 10 | MP0008875_abnormal_xenobiotic_pharmacok | 2.88783523 |
| 11 | MP0005670_abnormal_white_adipose | 2.85934109 |
| 12 | MP0008438_abnormal_cutaneous_collagen | 2.42387317 |
| 13 | * MP0003191_abnormal_cellular_cholesterol | 2.34496472 |
| 14 | MP0003705_abnormal_hypodermis_morpholog | 2.24101598 |
| 15 | MP0003690_abnormal_glial_cell | 2.20654841 |
| 16 | MP0003195_calcinosis | 2.17874660 |
| 17 | MP0005058_abnormal_lysosome_morphology | 2.11184451 |
| 18 | MP0004130_abnormal_muscle_cell | 2.08569494 |
| 19 | * MP0000609_abnormal_liver_physiology | 2.07945875 |
| 20 | MP0005083_abnormal_biliary_tract | 1.98009754 |
| 21 | * MP0002118_abnormal_lipid_homeostasis | 1.97913196 |
| 22 | MP0003300_gastrointestinal_ulcer | 1.85633771 |
| 23 | MP0005332_abnormal_amino_acid | 1.84706092 |
| 24 | MP0005666_abnormal_adipose_tissue | 1.73881209 |
| 25 | MP0003724_increased_susceptibility_to | 1.70813976 |
| 26 | MP0003941_abnormal_skin_development | 1.68591861 |
| 27 | MP0005167_abnormal_blood-brain_barrier | 1.56607300 |
| 28 | MP0005257_abnormal_intraocular_pressure | 1.53904051 |
| 29 | MP0003950_abnormal_plasma_membrane | 1.51383263 |
| 30 | MP0003329_amyloid_beta_deposits | 1.51274388 |
| 31 | MP0010368_abnormal_lymphatic_system | 1.50424329 |
| 32 | * MP0001666_abnormal_nutrient_absorption | 1.49686350 |
| 33 | MP0001984_abnormal_olfaction | 1.47162767 |
| 34 | MP0003436_decreased_susceptibility_to | 1.45418273 |
| 35 | MP0005319_abnormal_enzyme/_coenzyme | 1.45198114 |
| 36 | MP0003303_peritoneal_inflammation | 1.43409824 |
| 37 | * MP0001915_intracranial_hemorrhage | 1.36697675 |
| 38 | MP0002138_abnormal_hepatobiliary_system | 1.36452412 |
| 39 | MP0002148_abnormal_hypersensitivity_rea | 1.35342531 |
| 40 | MP0005451_abnormal_body_composition | 1.33894335 |
| 41 | MP0003890_abnormal_embryonic-extraembry | 1.33453148 |
| 42 | MP0003075_altered_response_to | 1.33293344 |
| 43 | MP0009764_decreased_sensitivity_to | 1.31586435 |
| 44 | MP0002971_abnormal_brown_adipose | 1.31515681 |
| 45 | MP0004510_myositis | 1.30418881 |
| 46 | MP0003806_abnormal_nucleotide_metabolis | 1.29312424 |
| 47 | MP0003172_abnormal_lysosome_physiology | 1.29293543 |
| 48 | MP0003045_fibrosis | 1.28953968 |
| 49 | MP0004185_abnormal_adipocyte_glucose | 1.28426292 |
| 50 | MP0003868_abnormal_feces_composition | 1.24995592 |
| 51 | MP0009785_altered_susceptibility_to | 1.24242913 |
| 52 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.24001102 |
| 53 | MP0005334_abnormal_fat_pad | 1.23814169 |
| 54 | MP0005275_abnormal_skin_tensile | 1.23548122 |
| 55 | * MP0000604_amyloidosis | 1.23021483 |
| 56 | * MP0004019_abnormal_vitamin_homeostasis | 1.22070876 |
| 57 | MP0005375_adipose_tissue_phenotype | 1.19439006 |
| 58 | MP0000920_abnormal_myelination | 1.17788527 |
| 59 | MP0002168_other_aberrant_phenotype | 1.17531862 |
| 60 | MP0000569_abnormal_digit_pigmentation | 1.17518105 |
| 61 | MP0009643_abnormal_urine_homeostasis | 1.15711966 |
| 62 | MP0009115_abnormal_fat_cell | 1.13969248 |
| 63 | MP0002332_abnormal_exercise_endurance | 1.13963888 |
| 64 | MP0001533_abnormal_skeleton_physiology | 1.11326039 |
| 65 | MP0009763_increased_sensitivity_to | 1.11208115 |
| 66 | MP0001661_extended_life_span | 1.10560375 |
| 67 | MP0003633_abnormal_nervous_system | 1.10272464 |
| 68 | MP0006082_CNS_inflammation | 1.10086345 |
| 69 | MP0001958_emphysema | 1.09022975 |
| 70 | MP0003279_aneurysm | 1.07359229 |
| 71 | * MP0008469_abnormal_protein_level | 1.06912609 |
| 72 | MP0005647_abnormal_sex_gland | 1.06025330 |
| 73 | * MP0002419_abnormal_innate_immunity | 1.04743090 |
| 74 | MP0003632_abnormal_nervous_system | 1.04274638 |
| 75 | MP0000598_abnormal_liver_morphology | 1.03446282 |
| 76 | MP0003448_altered_tumor_morphology | 1.03092992 |
| 77 | MP0003828_pulmonary_edema | 1.00857084 |
| 78 | MP0005164_abnormal_response_to | 1.00568257 |
| 79 | MP0003011_delayed_dark_adaptation | 0.96530155 |
| 80 | MP0004883_abnormal_blood_vessel | 0.96484800 |
| 81 | MP0004272_abnormal_basement_membrane | 0.96163523 |
| 82 | * MP0005464_abnormal_platelet_physiology | 0.96135150 |
| 83 | MP0002078_abnormal_glucose_homeostasis | 0.95343409 |
| 84 | MP0004484_altered_response_of | 0.93041756 |
| 85 | MP0005535_abnormal_body_temperature | 0.92214933 |
| 86 | MP0000249_abnormal_blood_vessel | 0.91762001 |
| 87 | MP0009384_cardiac_valve_regurgitation | 0.91084273 |
| 88 | MP0009780_abnormal_chondrocyte_physiolo | 0.90742259 |
| 89 | MP0002166_altered_tumor_susceptibility | 0.89094754 |
| 90 | MP0000343_altered_response_to | 0.88862880 |
| 91 | MP0000013_abnormal_adipose_tissue | 0.88478738 |
| 92 | * MP0000639_abnormal_adrenal_gland | 0.88043105 |
| 93 | MP0005166_decreased_susceptibility_to | 0.87755173 |
| 94 | MP0001756_abnormal_urination | 0.87606445 |
| 95 | MP0003453_abnormal_keratinocyte_physiol | 0.85253884 |
| 96 | MP0002928_abnormal_bile_duct | 0.84836356 |
| 97 | MP0003566_abnormal_cell_adhesion | 0.84735332 |
| 98 | MP0000767_abnormal_smooth_muscle | 0.84612564 |
| 99 | MP0001835_abnormal_antigen_presentation | 0.83635282 |
| 100 | MP0010352_gastrointestinal_tract_polyps | 0.82683618 |
| 101 | MP0010678_abnormal_skin_adnexa | 0.82674140 |
| 102 | * MP0002295_abnormal_pulmonary_circulatio | 0.82258127 |
| 103 | MP0005165_increased_susceptibility_to | 0.82217028 |
| 104 | MP0002896_abnormal_bone_mineralization | 0.81447177 |
| 105 | MP0005448_abnormal_energy_balance | 0.81066944 |
| 106 | MP0003656_abnormal_erythrocyte_physiolo | 0.81057218 |
| 107 | MP0001879_abnormal_lymphatic_vessel | 0.80407454 |
| 108 | MP0001790_abnormal_immune_system | 0.80032294 |
| 109 | MP0005387_immune_system_phenotype | 0.80032294 |
| 110 | MP0003221_abnormal_cardiomyocyte_apopto | 0.78632468 |
| 111 | MP0009697_abnormal_copulation | 0.77858905 |
| 112 | MP0000371_diluted_coat_color | 0.77234206 |
| 113 | MP0003631_nervous_system_phenotype | 0.77213725 |
| 114 | * MP0009642_abnormal_blood_homeostasis | 0.77146196 |
| 115 | MP0002998_abnormal_bone_remodeling | 0.76785684 |
| 116 | MP0001324_abnormal_eye_pigmentation | 0.76272959 |
| 117 | MP0001853_heart_inflammation | 0.74862028 |
| 118 | MP0002090_abnormal_vision | 0.74723727 |
| 119 | MP0004858_abnormal_nervous_system | 0.74020486 |
| 120 | MP0000647_abnormal_sebaceous_gland | 0.73943021 |
| 121 | MP0003186_abnormal_redox_activity | 0.73050656 |
| 122 | MP0003634_abnormal_glial_cell | 0.72636385 |
| 123 | MP0000003_abnormal_adipose_tissue | 0.72466810 |
| 124 | MP0002060_abnormal_skin_morphology | 0.72427644 |
| 125 | MP0001764_abnormal_homeostasis | 0.70300351 |
| 126 | MP0008260_abnormal_autophagy | 0.70269038 |
| 127 | MP0005367_renal/urinary_system_phenotyp | 0.69858001 |
| 128 | MP0000516_abnormal_urinary_system | 0.69858001 |
| 129 | MP0002909_abnormal_adrenal_gland | 0.69365712 |
| 130 | MP0002133_abnormal_respiratory_system | 0.68537177 |
| 131 | MP0005388_respiratory_system_phenotype | 0.68537177 |
| 132 | MP0010386_abnormal_urinary_bladder | 0.66663665 |
| 133 | MP0000383_abnormal_hair_follicle | 0.66341610 |
| 134 | MP0005248_abnormal_Harderian_gland | 0.65696669 |
| 135 | * MP0001845_abnormal_inflammatory_respons | 0.63503401 |
| 136 | MP0010234_abnormal_vibrissa_follicle | 0.63137395 |
| 137 | MP0005023_abnormal_wound_healing | 0.62869811 |
| 138 | * MP0002136_abnormal_kidney_physiology | 0.62848037 |
| 139 | MP0003183_abnormal_peptide_metabolism | 0.62321545 |
| 140 | MP0003091_abnormal_cell_migration | 0.60882275 |
| 141 | MP0005595_abnormal_vascular_smooth | 0.59906322 |
| 142 | MP0004947_skin_inflammation | 0.59707223 |
| 143 | MP0001881_abnormal_mammary_gland | 0.59480086 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Complement deficiency (HP:0004431) | 6.35818228 |
| 2 | Abnormality of glycolipid metabolism (HP:0010969) | 5.59905656 |
| 3 | Abnormality of liposaccharide metabolism (HP:0010968) | 5.59905656 |
| 4 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 5.59905656 |
| 5 | Deep venous thrombosis (HP:0002625) | 5.47784958 |
| 6 | Xanthomatosis (HP:0000991) | 5.21524725 |
| 7 | Systemic lupus erythematosus (HP:0002725) | 5.04433214 |
| 8 | Intrahepatic cholestasis (HP:0001406) | 4.87742004 |
| 9 | Abnormality of complement system (HP:0005339) | 4.75646809 |
| 10 | Prolonged partial thromboplastin time (HP:0003645) | 4.40953487 |
| 11 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 4.27011715 |
| 12 | Joint hemorrhage (HP:0005261) | 4.19421545 |
| 13 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 4.17944544 |
| 14 | Hyperlipoproteinemia (HP:0010980) | 4.11608877 |
| 15 | Abnormality of the common coagulation pathway (HP:0010990) | 4.02280115 |
| 16 | Epidermoid cyst (HP:0200040) | 3.97671423 |
| 17 | Glomerulonephritis (HP:0000099) | 3.92430902 |
| 18 | Hypoglycemic coma (HP:0001325) | 3.80994904 |
| 19 | Disinhibition (HP:0000734) | 3.64632953 |
| 20 | Hypobetalipoproteinemia (HP:0003563) | 3.48147437 |
| 21 | * Myocardial infarction (HP:0001658) | 3.39002063 |
| 22 | Recurrent gram-negative bacterial infections (HP:0005420) | 3.33031986 |
| 23 | * Hypoalphalipoproteinemia (HP:0003233) | 3.28586574 |
| 24 | Hypercholesterolemia (HP:0003124) | 3.25687053 |
| 25 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 3.21755004 |
| 26 | Ketosis (HP:0001946) | 3.21119047 |
| 27 | Nuclear cataract (HP:0100018) | 3.18794996 |
| 28 | Loss of speech (HP:0002371) | 3.15107530 |
| 29 | * Hypolipoproteinemia (HP:0010981) | 3.13889954 |
| 30 | Skin nodule (HP:0200036) | 3.10528988 |
| 31 | Abnormality of macrophages (HP:0004311) | 3.10223434 |
| 32 | * Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 3.06974140 |
| 33 | Hyperammonemia (HP:0001987) | 3.05587023 |
| 34 | Abnormality of the intrinsic pathway (HP:0010989) | 2.99417484 |
| 35 | Hyperglycinuria (HP:0003108) | 2.93415445 |
| 36 | Nephritis (HP:0000123) | 2.91213139 |
| 37 | Hypoglycemic seizures (HP:0002173) | 2.89663794 |
| 38 | Amyloidosis (HP:0011034) | 2.82148925 |
| 39 | Ketoacidosis (HP:0001993) | 2.76678609 |
| 40 | Retrobulbar optic neuritis (HP:0100654) | 2.73375621 |
| 41 | Optic neuritis (HP:0100653) | 2.73375621 |
| 42 | Mitral stenosis (HP:0001718) | 2.73192045 |
| 43 | Fat malabsorption (HP:0002630) | 2.69920805 |
| 44 | Cerebral aneurysm (HP:0004944) | 2.66697500 |
| 45 | Abnormality of secondary sexual hair (HP:0009888) | 2.66402602 |
| 46 | Abnormality of the axillary hair (HP:0100134) | 2.66402602 |
| 47 | Abnormality of glycine metabolism (HP:0010895) | 2.64683616 |
| 48 | Abnormality of serine family amino acid metabolism (HP:0010894) | 2.64683616 |
| 49 | Orchitis (HP:0100796) | 2.64045083 |
| 50 | Esophageal varix (HP:0002040) | 2.64037873 |
| 51 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 2.60537392 |
| 52 | Mutism (HP:0002300) | 2.59325073 |
| 53 | Conjugated hyperbilirubinemia (HP:0002908) | 2.55107434 |
| 54 | Dysostosis multiplex (HP:0000943) | 2.53219948 |
| 55 | Hyperglycinemia (HP:0002154) | 2.51071881 |
| 56 | Hemorrhage of the eye (HP:0011885) | 2.45025093 |
| 57 | Mucopolysacchariduria (HP:0008155) | 2.44868306 |
| 58 | Urinary glycosaminoglycan excretion (HP:0003541) | 2.44868306 |
| 59 | Abnormality of proline metabolism (HP:0010907) | 2.42369832 |
| 60 | Hydroxyprolinuria (HP:0003080) | 2.42369832 |
| 61 | Abnormality of the vasculature of the conjunctiva (HP:0008054) | 2.38420758 |
| 62 | Hyperinsulinemic hypoglycemia (HP:0000825) | 2.38186554 |
| 63 | Abnormality of the periventricular white matter (HP:0002518) | 2.37828699 |
| 64 | Cerebral inclusion bodies (HP:0100314) | 2.37675077 |
| 65 | Hepatocellular carcinoma (HP:0001402) | 2.37565168 |
| 66 | Hematochezia (HP:0002573) | 2.36286664 |
| 67 | Retinal atrophy (HP:0001105) | 2.35204932 |
| 68 | Increased cerebral lipofuscin (HP:0011813) | 2.32755141 |
| 69 | Axonal loss (HP:0003447) | 2.31629997 |
| 70 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.29985346 |
| 71 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.29985346 |
| 72 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.29985346 |
| 73 | Inappropriate behavior (HP:0000719) | 2.28696664 |
| 74 | Gingival bleeding (HP:0000225) | 2.28262651 |
| 75 | Papillary thyroid carcinoma (HP:0002895) | 2.22895474 |
| 76 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 2.21034625 |
| 77 | Abnormality of methionine metabolism (HP:0010901) | 2.19719719 |
| 78 | Abnormality of fatty-acid metabolism (HP:0004359) | 2.17136091 |
| 79 | Hypertriglyceridemia (HP:0002155) | 2.16975266 |
| 80 | Upper motor neuron abnormality (HP:0002127) | 2.16354688 |
| 81 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 2.15459210 |
| 82 | Metaphyseal irregularity (HP:0003025) | 2.15076967 |
| 83 | Pulmonary artery stenosis (HP:0004415) | 2.12596578 |
| 84 | Hyperglycemia (HP:0003074) | 2.12016780 |
| 85 | Aortic aneurysm (HP:0004942) | 2.10427452 |
| 86 | Spontaneous abortion (HP:0005268) | 2.10361764 |
| 87 | Flared iliac wings (HP:0002869) | 2.09853228 |
| 88 | Sensorimotor neuropathy (HP:0007141) | 2.09405488 |
| 89 | Increased CSF protein (HP:0002922) | 2.08362596 |
| 90 | Vacuolated lymphocytes (HP:0001922) | 2.07569457 |
| 91 | Aortic dissection (HP:0002647) | 2.05991181 |
| 92 | Tetraparesis (HP:0002273) | 2.01481381 |
| 93 | Abnormality of purine metabolism (HP:0004352) | 1.99594671 |
| 94 | Turricephaly (HP:0000262) | 1.96100766 |
| 95 | Spondylolisthesis (HP:0003302) | 1.95774074 |
| 96 | Peritonitis (HP:0002586) | 1.93338269 |
| 97 | Cardiovascular calcification (HP:0011915) | 1.92512532 |
| 98 | Spastic diplegia (HP:0001264) | 1.91907932 |
| 99 | Vascular calcification (HP:0004934) | 1.91619310 |
| 100 | Autoimmune thrombocytopenia (HP:0001973) | 1.91117516 |
| 101 | Ovoid vertebral bodies (HP:0003300) | 1.90884098 |
| 102 | Spontaneous hematomas (HP:0007420) | 1.88630524 |
| 103 | Abnormality of nucleobase metabolism (HP:0010932) | 1.88482729 |
| 104 | Keratoconjunctivitis sicca (HP:0001097) | 1.87473730 |
| 105 | Menorrhagia (HP:0000132) | 1.87357914 |
| 106 | Striae distensae (HP:0001065) | 1.87287076 |
| 107 | Arterial tortuosity (HP:0005116) | 1.86621573 |
| 108 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 1.85134842 |
| 109 | Symptomatic seizures (HP:0011145) | 1.84645153 |
| 110 | Mitral valve prolapse (HP:0001634) | 1.84274313 |
| 111 | Cervical subluxation (HP:0003308) | 1.84169712 |
| 112 | Pigmentary retinal degeneration (HP:0001146) | 1.83551132 |
| 113 | Mesangial abnormality (HP:0001966) | 1.83228654 |
| 114 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 1.82840425 |
| 115 | Osteolytic defects of the hand bones (HP:0009699) | 1.82840425 |
| 116 | Aneurysm (HP:0002617) | 1.80519697 |
| 117 | Pancreatitis (HP:0001733) | 1.80382926 |
| 118 | Thick nail (HP:0001805) | 1.79812612 |
| 119 | Portal hypertension (HP:0001409) | 1.79317619 |
| 120 | Vascular tortuosity (HP:0004948) | 1.79032716 |
| 121 | Neurofibrillary tangles (HP:0002185) | 1.78357780 |
| 122 | Recurrent bacterial skin infections (HP:0005406) | 1.77742036 |
| 123 | Intestinal atresia (HP:0011100) | 1.77625737 |
| 124 | Eczematoid dermatitis (HP:0000976) | 1.76615705 |
| 125 | Stroke (HP:0001297) | 1.76444498 |
| 126 | Steatorrhea (HP:0002570) | 1.76313543 |
| 127 | Hyperbilirubinemia (HP:0002904) | 1.76043925 |
| 128 | Beaking of vertebral bodies (HP:0004568) | 1.74639828 |
| 129 | Thrombophlebitis (HP:0004418) | 1.73887003 |
| 130 | Colitis (HP:0002583) | 1.73603679 |
| 131 | Late onset (HP:0003584) | 1.72332006 |
| 132 | Aplasia/Hypoplasia involving the sinuses (HP:0009120) | 1.71380394 |
| 133 | Conjunctival telangiectasia (HP:0000524) | 1.69902269 |
| 134 | Keratoconjunctivitis (HP:0001096) | 1.68960802 |
| 135 | Pathologic fracture (HP:0002756) | 1.64107816 |
| 136 | Myositis (HP:0100614) | 1.63363077 |
| 137 | Absent frontal sinuses (HP:0002688) | 1.62473338 |
| 138 | Agnosia (HP:0010524) | 1.61545041 |
| 139 | Recurrent abscess formation (HP:0002722) | 1.60947135 |
| 140 | Asymmetric septal hypertrophy (HP:0001670) | 1.59111666 |
| 141 | Pulmonic stenosis (HP:0001642) | 1.59051464 |
| 142 | Polyneuropathy (HP:0001271) | 1.58620492 |
| 143 | Tubulointerstitial fibrosis (HP:0005576) | 1.52237207 |
| 144 | Prolonged neonatal jaundice (HP:0006579) | 1.51467703 |
| 145 | Gonadal dysgenesis (HP:0000133) | 1.51117454 |
| 146 | Adactyly (HP:0009776) | 1.51071710 |
| 147 | Albinism (HP:0001022) | 1.49550229 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ACVR1B | 3.59202829 |
| 2 | TGFBR2 | 3.51816685 |
| 3 | SIK1 | 3.50498666 |
| 4 | ERN1 | 3.35639912 |
| 5 | INSRR | 3.29459012 |
| 6 | CAMK1D | 3.28314503 |
| 7 | AKT3 | 3.14787688 |
| 8 | DDR2 | 2.93021410 |
| 9 | TRIB3 | 2.78699221 |
| 10 | CAMK1G | 2.56532366 |
| 11 | FGFR4 | 2.45948911 |
| 12 | TRIM28 | 2.27718150 |
| 13 | RIPK1 | 2.14459876 |
| 14 | BCKDK | 2.06499377 |
| 15 | TAOK3 | 2.05466229 |
| 16 | TYK2 | 1.96187443 |
| 17 | PTK6 | 1.83005242 |
| 18 | ADRBK2 | 1.81234455 |
| 19 | TNIK | 1.79555309 |
| 20 | JAK1 | 1.78086252 |
| 21 | MAP4K2 | 1.77043698 |
| 22 | FRK | 1.68877420 |
| 23 | PBK | 1.68503633 |
| 24 | LATS1 | 1.68110966 |
| 25 | FGFR3 | 1.66232610 |
| 26 | GRK1 | 1.62056336 |
| 27 | MAP3K10 | 1.51298209 |
| 28 | NEK9 | 1.48596967 |
| 29 | ERBB3 | 1.47964447 |
| 30 | IRAK3 | 1.47382939 |
| 31 | EPHB1 | 1.46457252 |
| 32 | PKN2 | 1.46295870 |
| 33 | MAPK15 | 1.45409662 |
| 34 | FGR | 1.41790113 |
| 35 | NLK | 1.41142814 |
| 36 | CASK | 1.39750030 |
| 37 | EPHA3 | 1.37583522 |
| 38 | WNK3 | 1.37056264 |
| 39 | BMPR1B | 1.35492368 |
| 40 | PDGFRA | 1.34971706 |
| 41 | BCR | 1.33440103 |
| 42 | JAK2 | 1.32664829 |
| 43 | SIK3 | 1.28950937 |
| 44 | TBK1 | 1.23768077 |
| 45 | MAP3K14 | 1.23425457 |
| 46 | FGFR2 | 1.20860102 |
| 47 | TIE1 | 1.19876594 |
| 48 | MST1R | 1.19862532 |
| 49 | PRKAA2 | 1.19044774 |
| 50 | CSF1R | 1.08120334 |
| 51 | MAP3K4 | 1.06901516 |
| 52 | ERBB4 | 1.04041231 |
| 53 | PIK3CG | 1.01036816 |
| 54 | CSK | 1.00690083 |
| 55 | CDK6 | 0.98338023 |
| 56 | TTN | 0.95154332 |
| 57 | KDR | 0.94048483 |
| 58 | SGK3 | 0.93382317 |
| 59 | BLK | 0.93259351 |
| 60 | STK38L | 0.93072562 |
| 61 | EIF2AK3 | 0.90669991 |
| 62 | CDC42BPA | 0.89441447 |
| 63 | LMTK2 | 0.88855118 |
| 64 | PLK2 | 0.85556435 |
| 65 | IRAK2 | 0.85365999 |
| 66 | MAPK12 | 0.84564416 |
| 67 | GSK3A | 0.84506572 |
| 68 | MAP3K2 | 0.82091227 |
| 69 | IRAK4 | 0.82071254 |
| 70 | RET | 0.80819675 |
| 71 | FLT3 | 0.79820253 |
| 72 | KSR1 | 0.77598201 |
| 73 | MAPK11 | 0.77297144 |
| 74 | PRKCH | 0.77143584 |
| 75 | IKBKE | 0.76949933 |
| 76 | ERBB2 | 0.76551017 |
| 77 | IGF1R | 0.76550437 |
| 78 | JAK3 | 0.75537819 |
| 79 | ABL2 | 0.74238736 |
| 80 | MAP3K5 | 0.73875803 |
| 81 | PDGFRB | 0.72481566 |
| 82 | MET | 0.72375082 |
| 83 | SCYL2 | 0.71502618 |
| 84 | SGK2 | 0.70335236 |
| 85 | TGFBR1 | 0.69462333 |
| 86 | OBSCN | 0.68928167 |
| 87 | BMPR2 | 0.67461907 |
| 88 | PTK2 | 0.67139273 |
| 89 | DAPK2 | 0.66967448 |
| 90 | MAP3K3 | 0.65459925 |
| 91 | GRK7 | 0.64966264 |
| 92 | MAPK7 | 0.63699868 |
| 93 | MTOR | 0.63613330 |
| 94 | PRKCE | 0.62453835 |
| 95 | CDK9 | 0.62341167 |
| 96 | EGFR | 0.62323864 |
| 97 | PINK1 | 0.62276576 |
| 98 | FER | 0.62083640 |
| 99 | LATS2 | 0.61281707 |
| 100 | CHUK | 0.61273640 |
| 101 | MAP3K7 | 0.60401540 |
| 102 | FGFR1 | 0.60255277 |
| 103 | MELK | 0.59885178 |
| 104 | PDPK1 | 0.59739728 |
| 105 | PRKAA1 | 0.58560684 |
| 106 | PKN1 | 0.58413319 |
| 107 | KIT | 0.58189531 |
| 108 | TYRO3 | 0.55721110 |
| 109 | BMX | 0.55661161 |
| 110 | DYRK3 | 0.54647732 |
| 111 | CSNK1A1L | 0.54620814 |
| 112 | MAP3K13 | 0.54072997 |
| 113 | MAP3K6 | 0.53788205 |
| 114 | IRAK1 | 0.53763334 |
| 115 | CAMKK2 | 0.53726607 |
| 116 | PRKD1 | 0.53527064 |
| 117 | HCK | 0.52928219 |
| 118 | ITK | 0.52557488 |
| 119 | PDK2 | 0.51806824 |
| 120 | MAP2K3 | 0.51384466 |
| 121 | CSNK1G1 | 0.50909395 |
| 122 | MAP2K4 | 0.50853279 |
| 123 | STK3 | 0.50826981 |
| 124 | NUAK1 | 0.50329480 |
| 125 | YES1 | 0.49908870 |
| 126 | PDK1 | 0.48873977 |
| 127 | MOS | 0.48477466 |
| 128 | PAK2 | 0.47986241 |
| 129 | INSR | 0.47823694 |
| 130 | NTRK1 | 0.46754965 |
| 131 | MAP3K1 | 0.46279838 |
| 132 | STK24 | 0.46124151 |
| 133 | ABL1 | 0.44914555 |
| 134 | MAPK13 | 0.43886786 |
| 135 | IKBKB | 0.43882113 |
| 136 | * PRKACG | 0.43827765 |
| 137 | ROCK1 | 0.43276984 |
| 138 | CSNK1G2 | 0.42800073 |
| 139 | PAK3 | 0.42499358 |
| 140 | RIPK4 | 0.41881539 |
| 141 | MAP2K1 | 0.41013941 |
| 142 | DYRK1B | 0.40706961 |
| 143 | CDK12 | 0.39332982 |
| 144 | STK10 | 0.38934369 |
| 145 | MATK | 0.37522739 |
| 146 | SGK494 | 0.36605329 |
| 147 | SGK223 | 0.36605329 |
| 148 | PHKG1 | 0.36299255 |
| 149 | PHKG2 | 0.36299255 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Nitrogen metabolism_Homo sapiens_hsa00910 | 4.45813451 |
| 2 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 3.63322427 |
| 3 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 3.24139612 |
| 4 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 3.17145234 |
| 5 | Arginine biosynthesis_Homo sapiens_hsa00220 | 2.61483397 |
| 6 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.47575861 |
| 7 | PPAR signaling pathway_Homo sapiens_hsa03320 | 2.44240790 |
| 8 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 2.35976965 |
| 9 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 2.12466677 |
| 10 | Tryptophan metabolism_Homo sapiens_hsa00380 | 2.12379996 |
| 11 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.11615448 |
| 12 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 2.08874338 |
| 13 | Fatty acid metabolism_Homo sapiens_hsa01212 | 2.06110526 |
| 14 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.87041647 |
| 15 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.76576448 |
| 16 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 1.69981824 |
| 17 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 1.66397691 |
| 18 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.63312517 |
| 19 | Peroxisome_Homo sapiens_hsa04146 | 1.62652100 |
| 20 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 1.58983534 |
| 21 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 1.58304919 |
| 22 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 1.53326112 |
| 23 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.50433339 |
| 24 | Bile secretion_Homo sapiens_hsa04976 | 1.44758243 |
| 25 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 1.44295354 |
| 26 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.41231894 |
| 27 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.39996585 |
| 28 | Histidine metabolism_Homo sapiens_hsa00340 | 1.36817033 |
| 29 | * ABC transporters_Homo sapiens_hsa02010 | 1.32118406 |
| 30 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 1.26930461 |
| 31 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.24485766 |
| 32 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.23017288 |
| 33 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.22267346 |
| 34 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.18542832 |
| 35 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.16976512 |
| 36 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.15748084 |
| 37 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.10881519 |
| 38 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.07621307 |
| 39 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.07079681 |
| 40 | Mineral absorption_Homo sapiens_hsa04978 | 1.05785997 |
| 41 | Retinol metabolism_Homo sapiens_hsa00830 | 1.05620928 |
| 42 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.04310020 |
| 43 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.03973108 |
| 44 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 1.03878534 |
| 45 | Lysine degradation_Homo sapiens_hsa00310 | 1.02971832 |
| 46 | * Fat digestion and absorption_Homo sapiens_hsa04975 | 1.02353954 |
| 47 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 1.01281075 |
| 48 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.99530792 |
| 49 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.98962673 |
| 50 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.97647472 |
| 51 | Lysosome_Homo sapiens_hsa04142 | 0.94923551 |
| 52 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.92476759 |
| 53 | Insulin resistance_Homo sapiens_hsa04931 | 0.91649816 |
| 54 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 0.91197827 |
| 55 | Prion diseases_Homo sapiens_hsa05020 | 0.89429441 |
| 56 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.88756283 |
| 57 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.87213148 |
| 58 | Salmonella infection_Homo sapiens_hsa05132 | 0.87205411 |
| 59 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.85593144 |
| 60 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.83382863 |
| 61 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.80529958 |
| 62 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.78754072 |
| 63 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.78065325 |
| 64 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.76599008 |
| 65 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.74215921 |
| 66 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.70547548 |
| 67 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.68720983 |
| 68 | TGF-beta signaling pathway_Homo sapiens_hsa04350 | 0.67864570 |
| 69 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.64446787 |
| 70 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.62910628 |
| 71 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.62503038 |
| 72 | Malaria_Homo sapiens_hsa05144 | 0.59705293 |
| 73 | Other glycan degradation_Homo sapiens_hsa00511 | 0.57446887 |
| 74 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.57342978 |
| 75 | Carbon metabolism_Homo sapiens_hsa01200 | 0.56103549 |
| 76 | Osteoclast differentiation_Homo sapiens_hsa04380 | 0.54061914 |
| 77 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.51920193 |
| 78 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.51893610 |
| 79 | Pertussis_Homo sapiens_hsa05133 | 0.51820668 |
| 80 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.49863071 |
| 81 | Amoebiasis_Homo sapiens_hsa05146 | 0.48909678 |
| 82 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.48871773 |
| 83 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.45049651 |
| 84 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.44706919 |
| 85 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.43638587 |
| 86 | Circadian rhythm_Homo sapiens_hsa04710 | 0.43168265 |
| 87 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.42021294 |
| 88 | Leishmaniasis_Homo sapiens_hsa05140 | 0.42020851 |
| 89 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.40309881 |
| 90 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.38420751 |
| 91 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.38317921 |
| 92 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.37591789 |
| 93 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.37404029 |
| 94 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.37221096 |
| 95 | Galactose metabolism_Homo sapiens_hsa00052 | 0.36531138 |
| 96 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.36452395 |
| 97 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.36369776 |
| 98 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.35870727 |
| 99 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.35677536 |
| 100 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.35361875 |
| 101 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.35067266 |
| 102 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.34971865 |
| 103 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.34585202 |
| 104 | Influenza A_Homo sapiens_hsa05164 | 0.33997062 |
| 105 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.32346954 |
| 106 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.32229056 |
| 107 | Signaling pathways regulating pluripotency of stem cells_Homo sapiens_hsa04550 | 0.31782435 |
| 108 | Tuberculosis_Homo sapiens_hsa05152 | 0.31214751 |
| 109 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.30803024 |
| 110 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.30227670 |
| 111 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.28627598 |
| 112 | PI3K-Akt signaling pathway_Homo sapiens_hsa04151 | 0.28593318 |
| 113 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.28423092 |
| 114 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.27230157 |
| 115 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.26249021 |
| 116 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.26209253 |
| 117 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.25810710 |
| 118 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.25166727 |
| 119 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.25022443 |
| 120 | Focal adhesion_Homo sapiens_hsa04510 | 0.22555550 |
| 121 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.22106062 |
| 122 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.22007174 |
| 123 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.20923151 |
| 124 | Legionellosis_Homo sapiens_hsa05134 | 0.19537031 |
| 125 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.18675779 |
| 126 | Phagosome_Homo sapiens_hsa04145 | 0.18663977 |
| 127 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 0.18623616 |
| 128 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.18283083 |
| 129 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.17646146 |
| 130 | Hepatitis C_Homo sapiens_hsa05160 | 0.17471435 |
| 131 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.17277899 |
| 132 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.16571407 |
| 133 | Sulfur relay system_Homo sapiens_hsa04122 | 0.16526608 |
| 134 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.16388598 |
| 135 | Adherens junction_Homo sapiens_hsa04520 | 0.15585371 |

